JSC Lekhim pharmaceutical company (Kyiv) in 2017 posted UAH 101.7 million of net profit, which is 6% more than in 2016 (UAH 95.5 million).
According to information on the agenda of a general shareholders’ meeting scheduled for March 27, the assets of Lekhim amounted to UAH 647 million, which is 9.7% higher than in the previous year.
Total debtor indebtedness in 2017 decreased by 3.7%, to UAH 458 million.
As reported, in 2016 Lekhim saw net profit rise by 19% compared to 2015.
Lekhim was founded in 1992. The group of companies headed by Lekhim includes PrJSC Lekhim-Kharkiv and CJSC Technolog.
